

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | bile acid and bile salt transport (GO:0015721) | 6.07159236 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.95210167 |
| 3 | angiotensin maturation (GO:0002003) | 5.82717783 |
| 4 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.06206059 |
| 5 | desmosome organization (GO:0002934) | 4.97138218 |
| 6 | cellular ketone body metabolic process (GO:0046950) | 4.77480548 |
| 7 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.72654492 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 4.69504712 |
| 9 | regulation of protein glycosylation (GO:0060049) | 4.66603840 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 4.66486679 |
| 11 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.64087359 |
| 12 | lipoprotein transport (GO:0042953) | 4.44374110 |
| 13 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.37880546 |
| 14 | cellular glucuronidation (GO:0052695) | 4.36059734 |
| 15 | pantothenate metabolic process (GO:0015939) | 4.19782696 |
| 16 | NADH metabolic process (GO:0006734) | 4.18268671 |
| 17 | intestinal cholesterol absorption (GO:0030299) | 4.15302666 |
| 18 | glucuronate metabolic process (GO:0019585) | 4.12397576 |
| 19 | uronic acid metabolic process (GO:0006063) | 4.12397576 |
| 20 | ketone body metabolic process (GO:1902224) | 4.09098978 |
| 21 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.04981377 |
| 22 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.04981377 |
| 23 | hormone catabolic process (GO:0042447) | 4.02677585 |
| 24 | vitamin transmembrane transport (GO:0035461) | 4.00300741 |
| 25 | regulation of guanylate cyclase activity (GO:0031282) | 3.98699293 |
| 26 | cytidine deamination (GO:0009972) | 3.98328066 |
| 27 | cytidine metabolic process (GO:0046087) | 3.98328066 |
| 28 | cytidine catabolic process (GO:0006216) | 3.98328066 |
| 29 | plasma lipoprotein particle assembly (GO:0034377) | 3.91829932 |
| 30 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.90729022 |
| 31 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.90729022 |
| 32 | endocrine process (GO:0050886) | 3.90729022 |
| 33 | drug catabolic process (GO:0042737) | 3.89483885 |
| 34 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.88069211 |
| 35 | renal system process involved in regulation of blood volume (GO:0001977) | 3.88010229 |
| 36 | ethanol oxidation (GO:0006069) | 3.83729848 |
| 37 | urea metabolic process (GO:0019627) | 3.80958806 |
| 38 | urea cycle (GO:0000050) | 3.80209008 |
| 39 | intestinal absorption (GO:0050892) | 3.74500273 |
| 40 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.70543542 |
| 41 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.67549130 |
| 42 | protein-lipid complex assembly (GO:0065005) | 3.65675103 |
| 43 | coenzyme A biosynthetic process (GO:0015937) | 3.64148399 |
| 44 | negative regulation of sterol transport (GO:0032372) | 3.62516038 |
| 45 | negative regulation of cholesterol transport (GO:0032375) | 3.62516038 |
| 46 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.61274006 |
| 47 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.58281864 |
| 48 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.58281864 |
| 49 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.58281864 |
| 50 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.55315542 |
| 51 | negative regulation of complement activation (GO:0045916) | 3.53660214 |
| 52 | midgut development (GO:0007494) | 3.53376751 |
| 53 | actin filament depolymerization (GO:0030042) | 3.52601098 |
| 54 | drug transmembrane transport (GO:0006855) | 3.52376856 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.50462950 |
| 56 | L-phenylalanine catabolic process (GO:0006559) | 3.50462950 |
| 57 | nitrogen cycle metabolic process (GO:0071941) | 3.49903679 |
| 58 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.49519441 |
| 59 | negative regulation of protein activation cascade (GO:2000258) | 3.49151687 |
| 60 | flavonoid metabolic process (GO:0009812) | 3.47693661 |
| 61 | positive regulation of protein targeting to membrane (GO:0090314) | 3.47215056 |
| 62 | L-phenylalanine metabolic process (GO:0006558) | 3.46426888 |
| 63 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.46426888 |
| 64 | response to water (GO:0009415) | 3.44532729 |
| 65 | regulation of cholesterol homeostasis (GO:2000188) | 3.42925022 |
| 66 | thrombin receptor signaling pathway (GO:0070493) | 3.42547687 |
| 67 | regulation of systemic arterial blood pressure (GO:0003073) | 3.41251872 |
| 68 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 3.39123937 |
| 69 | nucleoside bisphosphate metabolic process (GO:0033865) | 3.39123937 |
| 70 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 3.39123937 |
| 71 | regulation of protein activation cascade (GO:2000257) | 3.38538159 |
| 72 | adhesion of symbiont to host cell (GO:0044650) | 3.35634973 |
| 73 | virion attachment to host cell (GO:0019062) | 3.35634973 |
| 74 | bile acid metabolic process (GO:0008206) | 3.35538814 |
| 75 | regulation of complement activation (GO:0030449) | 3.35362825 |
| 76 | lipoprotein metabolic process (GO:0042157) | 3.32387072 |
| 77 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.24650726 |
| 78 | lung vasculature development (GO:0060426) | 3.23747862 |
| 79 | macrophage chemotaxis (GO:0048246) | 3.22710914 |
| 80 | regulation of cGMP biosynthetic process (GO:0030826) | 3.17564221 |
| 81 | drug metabolic process (GO:0017144) | 3.16258457 |
| 82 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.16013455 |
| 83 | phospholipid efflux (GO:0033700) | 3.15680605 |
| 84 | adhesion of symbiont to host (GO:0044406) | 3.14801236 |
| 85 | epithelial structure maintenance (GO:0010669) | 3.12281073 |
| 86 | cell adhesion mediated by integrin (GO:0033627) | 3.10501371 |
| 87 | peptide catabolic process (GO:0043171) | 3.10163919 |
| 88 | protein carboxylation (GO:0018214) | 3.09747125 |
| 89 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.09747125 |
| 90 | intestinal epithelial cell development (GO:0060576) | 3.07569717 |
| 91 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.06731550 |
| 92 | high-density lipoprotein particle remodeling (GO:0034375) | 3.05501824 |
| 93 | protein-lipid complex remodeling (GO:0034368) | 3.05084154 |
| 94 | macromolecular complex remodeling (GO:0034367) | 3.05084154 |
| 95 | plasma lipoprotein particle remodeling (GO:0034369) | 3.05084154 |
| 96 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.03706987 |
| 97 | exogenous drug catabolic process (GO:0042738) | 3.03144801 |
| 98 | hemidesmosome assembly (GO:0031581) | 3.01003558 |
| 99 | drug transport (GO:0015893) | 2.98309355 |
| 100 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.98018460 |
| 101 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.97606964 |
| 102 | renal filtration (GO:0097205) | 2.94890149 |
| 103 | thyroid hormone metabolic process (GO:0042403) | 2.93776852 |
| 104 | ethanol metabolic process (GO:0006067) | 2.93421789 |
| 105 | glomerular filtration (GO:0003094) | 2.92910261 |
| 106 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.92744070 |
| 107 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.92075095 |
| 108 | aromatic amino acid family catabolic process (GO:0009074) | 2.92021995 |
| 109 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.90961932 |
| 110 | cholesterol efflux (GO:0033344) | 2.90804373 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 2.90785828 |
| 112 | diacylglycerol metabolic process (GO:0046339) | 2.90255327 |
| 113 | sulfate transmembrane transport (GO:1902358) | 2.89696215 |
| 114 | regulation of cholesterol esterification (GO:0010872) | 2.86847056 |
| 115 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.86638274 |
| 116 | negative regulation of protein autophosphorylation (GO:0031953) | 2.86396399 |
| 117 | antibacterial humoral response (GO:0019731) | 2.86351111 |
| 118 | thyroid hormone generation (GO:0006590) | 2.86222011 |
| 119 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.86209655 |
| 120 | polyketide metabolic process (GO:0030638) | 2.85304524 |
| 121 | doxorubicin metabolic process (GO:0044598) | 2.85304524 |
| 122 | daunorubicin metabolic process (GO:0044597) | 2.85304524 |
| 123 | positive regulation of lipid catabolic process (GO:0050996) | 2.85287355 |
| 124 | endocardial cushion development (GO:0003197) | 2.84810374 |
| 125 | coenzyme A metabolic process (GO:0015936) | 2.84242737 |
| 126 | protein retention in ER lumen (GO:0006621) | 2.84165638 |
| 127 | glucose 6-phosphate metabolic process (GO:0051156) | 2.84075048 |
| 128 | response to nitrosative stress (GO:0051409) | 2.83511319 |
| 129 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.83508773 |
| 130 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.83508773 |
| 131 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.83210864 |
| 132 | protein-lipid complex subunit organization (GO:0071825) | 2.82643443 |
| 133 | membrane budding (GO:0006900) | 2.82044673 |
| 134 | transcytosis (GO:0045056) | 2.81269103 |
| 135 | positive regulation of extracellular matrix organization (GO:1903055) | 2.81205995 |
| 136 | complement activation, classical pathway (GO:0006958) | 2.81023736 |
| 137 | fructose metabolic process (GO:0006000) | 2.80396086 |
| 138 | phosphate ion transmembrane transport (GO:0035435) | 2.80323154 |
| 139 | digestive system process (GO:0022600) | 2.79976606 |
| 140 | positive regulation of pseudopodium assembly (GO:0031274) | 2.79368528 |
| 141 | COPII vesicle coating (GO:0048208) | 2.79342089 |
| 142 | negative regulation of blood coagulation (GO:0030195) | 2.78248269 |
| 143 | negative regulation of hemostasis (GO:1900047) | 2.78248269 |
| 144 | cholesterol homeostasis (GO:0042632) | 2.77156749 |
| 145 | arginine metabolic process (GO:0006525) | 2.76282533 |
| 146 | regulation of triglyceride catabolic process (GO:0010896) | 2.75992331 |
| 147 | digestion (GO:0007586) | 2.75046884 |
| 148 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.74345237 |
| 149 | regulation of vitamin metabolic process (GO:0030656) | 2.74222463 |
| 150 | sterol homeostasis (GO:0055092) | 2.73818422 |
| 151 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.73512288 |
| 152 | negative regulation of coagulation (GO:0050819) | 2.72694107 |
| 153 | bile acid biosynthetic process (GO:0006699) | 2.71689888 |
| 154 | negative regulation of fibrinolysis (GO:0051918) | 2.71352741 |
| 155 | regulation of metalloenzyme activity (GO:0048552) | 2.70708509 |
| 156 | antimicrobial humoral response (GO:0019730) | 2.70092737 |
| 157 | benzene-containing compound metabolic process (GO:0042537) | 2.69319672 |
| 158 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.69233589 |
| 159 | regulation of protein targeting to membrane (GO:0090313) | 2.65706522 |
| 160 | hydrogen peroxide catabolic process (GO:0042744) | 2.64794234 |
| 161 | cGMP-mediated signaling (GO:0019934) | 2.64537062 |
| 162 | vitamin transport (GO:0051180) | 2.64215951 |
| 163 | regulation of bile acid biosynthetic process (GO:0070857) | 2.64057538 |
| 164 | reverse cholesterol transport (GO:0043691) | 2.64053193 |
| 165 | xenobiotic catabolic process (GO:0042178) | 2.63609614 |
| 166 | regulation of cGMP metabolic process (GO:0030823) | 2.63148451 |
| 167 | cellular zinc ion homeostasis (GO:0006882) | 2.62909371 |
| 168 | kynurenine metabolic process (GO:0070189) | 2.62489907 |
| 169 | acute-phase response (GO:0006953) | 2.61866857 |
| 170 | glyoxylate metabolic process (GO:0046487) | 2.61540022 |
| 171 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.61003640 |
| 172 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.60371798 |
| 173 | cysteine metabolic process (GO:0006534) | 2.58244533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.43753348 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.60772979 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.24319869 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.90531065 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.38270273 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.26111471 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.08351789 |
| 8 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.93933431 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.93048742 |
| 10 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.85575759 |
| 11 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.82663193 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.73255339 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.71630370 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.68385548 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.63607971 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.57074240 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.56559517 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.53693761 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.53637056 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.47770684 |
| 21 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.35452203 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.31777528 |
| 23 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.31361073 |
| 24 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.30349202 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.29712937 |
| 26 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.10740242 |
| 27 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.06980124 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.03902517 |
| 29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.97248680 |
| 30 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.94341980 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.94223231 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.88824312 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86942224 |
| 34 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84161992 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79461024 |
| 36 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.78410045 |
| 37 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.78322431 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77625717 |
| 39 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.69346580 |
| 40 | ATF3_27146783_Chip-Seq_COLON_Human | 1.54751414 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.51015948 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49008413 |
| 43 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42447139 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42161183 |
| 45 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.41797568 |
| 46 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40149504 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38571515 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38571515 |
| 49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36298187 |
| 50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34380977 |
| 51 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32838688 |
| 52 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.32429230 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31582626 |
| 54 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.31248395 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30205798 |
| 56 | CJUN_26792858_Chip-Seq_BT549_Human | 1.29987819 |
| 57 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.29665848 |
| 58 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.29665848 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29537933 |
| 60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28866705 |
| 61 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.28736794 |
| 62 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.28411797 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26528128 |
| 64 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.24805465 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23762455 |
| 66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22977411 |
| 67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18528953 |
| 68 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17741937 |
| 69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15314690 |
| 70 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13844481 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13056057 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11329086 |
| 73 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.11066337 |
| 74 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.09427507 |
| 75 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07852343 |
| 76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07532364 |
| 77 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.07222576 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07079206 |
| 79 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06641392 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06379943 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06043495 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05544914 |
| 83 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05017872 |
| 84 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04781120 |
| 85 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04654543 |
| 86 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.03766014 |
| 87 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01808767 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01492570 |
| 89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01035373 |
| 90 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.00362588 |
| 91 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99637525 |
| 92 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.99018942 |
| 93 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97046262 |
| 94 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.96481639 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95572850 |
| 96 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95521535 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95458017 |
| 98 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95250593 |
| 99 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.94851938 |
| 100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92162679 |
| 101 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92162679 |
| 102 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91670087 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91635912 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91038020 |
| 105 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.90752987 |
| 106 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90704405 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90355154 |
| 108 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90054091 |
| 109 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90050179 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88858641 |
| 111 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.88503618 |
| 112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88046559 |
| 113 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.87927685 |
| 114 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87522457 |
| 115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87416721 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87264311 |
| 117 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87251013 |
| 118 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.86285918 |
| 119 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86117548 |
| 120 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85917307 |
| 121 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85907551 |
| 122 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84701747 |
| 123 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83926086 |
| 124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83822271 |
| 125 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82997572 |
| 126 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.81857594 |
| 127 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.81617839 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80729269 |
| 129 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.79115518 |
| 130 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.77306390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 8.82580124 |
| 2 | MP0005360_urolithiasis | 4.61238759 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.94276686 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.90534877 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.28255047 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.19536887 |
| 7 | MP0005377_hearing/vestibular/ear_phenot | 3.04675344 |
| 8 | MP0003878_abnormal_ear_physiology | 3.04675344 |
| 9 | MP0005365_abnormal_bile_salt | 2.90783982 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.90402101 |
| 11 | MP0003283_abnormal_digestive_organ | 2.59636022 |
| 12 | MP0004264_abnormal_extraembryonic_tissu | 2.57896052 |
| 13 | MP0004147_increased_porphyrin_level | 2.55483601 |
| 14 | MP0003252_abnormal_bile_duct | 2.42637512 |
| 15 | MP0005083_abnormal_biliary_tract | 2.32676799 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.30817574 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.28977487 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.20029585 |
| 19 | MP0002822_catalepsy | 2.10226705 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.05311165 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.98914579 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.88925618 |
| 23 | MP0000462_abnormal_digestive_system | 1.88865802 |
| 24 | MP0005409_darkened_coat_color | 1.83104647 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.77479233 |
| 26 | MP0003950_abnormal_plasma_membrane | 1.75249551 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.56149626 |
| 28 | MP0002736_abnormal_nociception_after | 1.54412970 |
| 29 | MP0009840_abnormal_foam_cell | 1.54171509 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.53008438 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.45456942 |
| 32 | MP0005332_abnormal_amino_acid | 1.43202162 |
| 33 | MP0009384_cardiac_valve_regurgitation | 1.42419762 |
| 34 | MP0001664_abnormal_digestion | 1.42300188 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.42299025 |
| 36 | MP0004043_abnormal_pH_regulation | 1.41772445 |
| 37 | MP0009697_abnormal_copulation | 1.38638621 |
| 38 | MP0010678_abnormal_skin_adnexa | 1.36980961 |
| 39 | MP0003315_abnormal_perineum_morphology | 1.35466958 |
| 40 | MP0005670_abnormal_white_adipose | 1.31400055 |
| 41 | MP0005451_abnormal_body_composition | 1.28048436 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.26472833 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.25639032 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.25388563 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.22300321 |
| 46 | MP0000490_abnormal_crypts_of | 1.22244239 |
| 47 | MP0000477_abnormal_intestine_morphology | 1.22042994 |
| 48 | MP0006054_spinal_hemorrhage | 1.20473523 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.17430288 |
| 50 | MP0003866_abnormal_defecation | 1.16719256 |
| 51 | MP0005165_increased_susceptibility_to | 1.16161140 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.14939823 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.13004496 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 1.12381700 |
| 55 | MP0002118_abnormal_lipid_homeostasis | 1.11842627 |
| 56 | MP0002796_impaired_skin_barrier | 1.09918329 |
| 57 | MP0005381_digestive/alimentary_phenotyp | 1.09191973 |
| 58 | MP0001663_abnormal_digestive_system | 1.08506809 |
| 59 | MP0003186_abnormal_redox_activity | 1.08354155 |
| 60 | MP0003045_fibrosis | 1.06750766 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.06397468 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.04673076 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 1.04387135 |
| 64 | MP0009053_abnormal_anal_canal | 1.03159690 |
| 65 | MP0003091_abnormal_cell_migration | 1.02206364 |
| 66 | MP0008004_abnormal_stomach_pH | 1.01575436 |
| 67 | MP0005164_abnormal_response_to | 1.01134594 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 1.00901245 |
| 69 | MP0004019_abnormal_vitamin_homeostasis | 0.98843190 |
| 70 | MP0006138_congestive_heart_failure | 0.98248297 |
| 71 | MP0003868_abnormal_feces_composition | 0.97774007 |
| 72 | MP0005257_abnormal_intraocular_pressure | 0.96068566 |
| 73 | MP0000013_abnormal_adipose_tissue | 0.95374384 |
| 74 | MP0005023_abnormal_wound_healing | 0.94428659 |
| 75 | MP0005275_abnormal_skin_tensile | 0.93586381 |
| 76 | MP0002166_altered_tumor_susceptibility | 0.93142738 |
| 77 | MP0008775_abnormal_heart_ventricle | 0.93101124 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.92864002 |
| 79 | MP0000609_abnormal_liver_physiology | 0.92260343 |
| 80 | MP0005187_abnormal_penis_morphology | 0.90098483 |
| 81 | MP0004272_abnormal_basement_membrane | 0.89417585 |
| 82 | MP0002295_abnormal_pulmonary_circulatio | 0.88709421 |
| 83 | MP0000427_abnormal_hair_cycle | 0.88190305 |
| 84 | MP0002909_abnormal_adrenal_gland | 0.87771809 |
| 85 | MP0002009_preneoplasia | 0.87638596 |
| 86 | MP0001879_abnormal_lymphatic_vessel | 0.87544562 |
| 87 | MP0000604_amyloidosis | 0.86804468 |
| 88 | MP0004858_abnormal_nervous_system | 0.86760571 |
| 89 | MP0000249_abnormal_blood_vessel | 0.85920594 |
| 90 | MP0000538_abnormal_urinary_bladder | 0.84722956 |
| 91 | MP0000681_abnormal_thyroid_gland | 0.81844985 |
| 92 | MP0000762_abnormal_tongue_morphology | 0.79582135 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.78525409 |
| 94 | MP0005408_hypopigmentation | 0.78449015 |
| 95 | MP0000537_abnormal_urethra_morphology | 0.78306140 |
| 96 | MP0003195_calcinosis | 0.78192589 |
| 97 | MP0002060_abnormal_skin_morphology | 0.78015822 |
| 98 | MP0001873_stomach_inflammation | 0.77900520 |
| 99 | MP0001764_abnormal_homeostasis | 0.76208001 |
| 100 | MP0008789_abnormal_olfactory_epithelium | 0.76105596 |
| 101 | MP0002971_abnormal_brown_adipose | 0.75573357 |
| 102 | MP0003566_abnormal_cell_adhesion | 0.74892204 |
| 103 | MP0004883_abnormal_blood_vessel | 0.71533933 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.71233908 |
| 105 | MP0005595_abnormal_vascular_smooth | 0.69938001 |
| 106 | MP0001756_abnormal_urination | 0.69911490 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.69671402 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.68651360 |
| 109 | MP0000678_abnormal_parathyroid_gland | 0.68230098 |
| 110 | MP0003941_abnormal_skin_development | 0.66129192 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.64267702 |
| 112 | MP0003879_abnormal_hair_cell | 0.63927162 |
| 113 | MP0000613_abnormal_salivary_gland | 0.63053599 |
| 114 | MP0004484_altered_response_of | 0.62733308 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61135262 |
| 116 | MP0010771_integument_phenotype | 0.61075692 |
| 117 | MP0001958_emphysema | 0.60609212 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.60104514 |
| 119 | MP0002733_abnormal_thermal_nociception | 0.59890546 |
| 120 | MP0003279_aneurysm | 0.59560638 |
| 121 | MP0002098_abnormal_vibrissa_morphology | 0.59558248 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.59513040 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.58715838 |
| 124 | MP0002089_abnormal_postnatal_growth/wei | 0.58295767 |
| 125 | MP0009379_abnormal_foot_pigmentation | 0.56978876 |
| 126 | MP0000566_synostosis | 0.56813997 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.56547353 |
| 128 | MP0000858_altered_metastatic_potential | 0.55972770 |
| 129 | MP0001216_abnormal_epidermal_layer | 0.55816922 |
| 130 | MP0000470_abnormal_stomach_morphology | 0.55778261 |
| 131 | MP0002132_abnormal_respiratory_system | 0.55670710 |
| 132 | MP0000767_abnormal_smooth_muscle | 0.55570338 |
| 133 | MP0005166_decreased_susceptibility_to | 0.54350498 |
| 134 | MP0009115_abnormal_fat_cell | 0.54030091 |
| 135 | MP0001270_distended_abdomen | 0.53918577 |
| 136 | MP0001346_abnormal_lacrimal_gland | 0.53487779 |
| 137 | MP0005501_abnormal_skin_physiology | 0.53255420 |
| 138 | MP0003718_maternal_effect | 0.53107725 |
| 139 | MP0002006_tumorigenesis | 0.52899233 |
| 140 | MP0001765_abnormal_ion_homeostasis | 0.52121364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 4.61511328 |
| 2 | Flat acetabular roof (HP:0003180) | 4.32845448 |
| 3 | Abnormal tarsal ossification (HP:0008369) | 4.25387466 |
| 4 | Ileus (HP:0002595) | 4.23405396 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 3.93175459 |
| 6 | Pustule (HP:0200039) | 3.89226128 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.86527242 |
| 8 | Alopecia of scalp (HP:0002293) | 3.68680221 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.67252453 |
| 10 | Cupped ribs (HP:0000887) | 3.67050453 |
| 11 | Complement deficiency (HP:0004431) | 3.64924333 |
| 12 | Abnormality of the 1st metacarpal (HP:0010009) | 3.62487151 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61787603 |
| 14 | Abnormality of complement system (HP:0005339) | 3.33695614 |
| 15 | Abnormality of carpal bone ossification (HP:0006257) | 3.33397909 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.20747415 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.17612681 |
| 18 | Pili torti (HP:0003777) | 3.14351403 |
| 19 | Arterial tortuosity (HP:0005116) | 3.08751175 |
| 20 | Hemorrhage of the eye (HP:0011885) | 3.05051684 |
| 21 | Hyperactive renin-angiotensin system (HP:0000841) | 3.04993413 |
| 22 | Deep venous thrombosis (HP:0002625) | 2.96506055 |
| 23 | Chronic diarrhea (HP:0002028) | 2.94450961 |
| 24 | Aortic dissection (HP:0002647) | 2.93142717 |
| 25 | Xanthomatosis (HP:0000991) | 2.87318240 |
| 26 | Malnutrition (HP:0004395) | 2.86075122 |
| 27 | Abnormal foot bone ossification (HP:0010675) | 2.85244286 |
| 28 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.84247288 |
| 29 | Fat malabsorption (HP:0002630) | 2.82284346 |
| 30 | Esophageal varix (HP:0002040) | 2.82143085 |
| 31 | Glomerulonephritis (HP:0000099) | 2.77832361 |
| 32 | Abdominal distention (HP:0003270) | 2.70217080 |
| 33 | Decreased circulating renin level (HP:0003351) | 2.69832388 |
| 34 | Abnormality of vitamin metabolism (HP:0100508) | 2.68354524 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 2.67683752 |
| 36 | Aortic aneurysm (HP:0004942) | 2.66380413 |
| 37 | Abnormality of vitamin B metabolism (HP:0004340) | 2.58137346 |
| 38 | Curly hair (HP:0002212) | 2.56003197 |
| 39 | Villous atrophy (HP:0011473) | 2.55610659 |
| 40 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.55610659 |
| 41 | Proximal tubulopathy (HP:0000114) | 2.54187453 |
| 42 | Steatorrhea (HP:0002570) | 2.53877227 |
| 43 | Hydroxyprolinuria (HP:0003080) | 2.53583189 |
| 44 | Abnormality of proline metabolism (HP:0010907) | 2.53583189 |
| 45 | Protrusio acetabuli (HP:0003179) | 2.46445087 |
| 46 | Metabolic alkalosis (HP:0200114) | 2.44873761 |
| 47 | Absent phalangeal crease (HP:0006109) | 2.44398881 |
| 48 | Abnormal ossification of hand bones (HP:0005921) | 2.43283558 |
| 49 | Nephritis (HP:0000123) | 2.41924002 |
| 50 | Hypolipoproteinemia (HP:0010981) | 2.41445501 |
| 51 | Premature rupture of membranes (HP:0001788) | 2.41309054 |
| 52 | Abnormal hand bone ossification (HP:0010660) | 2.40571193 |
| 53 | Acute encephalopathy (HP:0006846) | 2.40187589 |
| 54 | Pigmentary retinal degeneration (HP:0001146) | 2.40144267 |
| 55 | Goiter (HP:0000853) | 2.36754600 |
| 56 | Widely patent fontanelles and sutures (HP:0004492) | 2.36690289 |
| 57 | Abnormal cartilage morphology (HP:0002763) | 2.36439463 |
| 58 | Abnormality of chloride homeostasis (HP:0011422) | 2.34834224 |
| 59 | Hypoglycemic coma (HP:0001325) | 2.34728662 |
| 60 | Short phalanx of the thumb (HP:0009660) | 2.34366709 |
| 61 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.34236504 |
| 62 | Abnormality of renin-angiotensin system (HP:0000847) | 2.32973424 |
| 63 | Abnormality of the 2nd finger (HP:0004100) | 2.32817792 |
| 64 | Progressive sensorineural hearing impairment (HP:0000408) | 2.32252429 |
| 65 | Abnormal hemoglobin (HP:0011902) | 2.31944830 |
| 66 | Glomerulosclerosis (HP:0000096) | 2.29200386 |
| 67 | Myokymia (HP:0002411) | 2.26804848 |
| 68 | Joint hemorrhage (HP:0005261) | 2.25498796 |
| 69 | Potter facies (HP:0002009) | 2.25195313 |
| 70 | Facial shape deformation (HP:0011334) | 2.25195313 |
| 71 | Short hallux (HP:0010109) | 2.24631667 |
| 72 | Vascular tortuosity (HP:0004948) | 2.23935790 |
| 73 | Cerebral edema (HP:0002181) | 2.22423363 |
| 74 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.21883608 |
| 75 | Osteolytic defects of the hand bones (HP:0009699) | 2.21449122 |
| 76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.21449122 |
| 77 | Gout (HP:0001997) | 2.20961332 |
| 78 | Vascular calcification (HP:0004934) | 2.20315867 |
| 79 | Thin bony cortex (HP:0002753) | 2.19550932 |
| 80 | Confusion (HP:0001289) | 2.19223842 |
| 81 | Acute necrotizing encephalopathy (HP:0006965) | 2.18235052 |
| 82 | Wide cranial sutures (HP:0010537) | 2.17834191 |
| 83 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.17275066 |
| 84 | Prolonged partial thromboplastin time (HP:0003645) | 2.16432867 |
| 85 | Myotonia (HP:0002486) | 2.16366932 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.12321074 |
| 87 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.12203702 |
| 88 | Cardiovascular calcification (HP:0011915) | 2.11589304 |
| 89 | Cervical subluxation (HP:0003308) | 2.11553598 |
| 90 | Fragile skin (HP:0001030) | 2.10455580 |
| 91 | Hypotension (HP:0002615) | 2.09982858 |
| 92 | Skin nodule (HP:0200036) | 2.08829124 |
| 93 | Acanthocytosis (HP:0001927) | 2.08807207 |
| 94 | Spontaneous abortion (HP:0005268) | 2.08777680 |
| 95 | Rectal prolapse (HP:0002035) | 2.07699751 |
| 96 | Renal tubular acidosis (HP:0001947) | 2.06652121 |
| 97 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.06505886 |
| 98 | Menorrhagia (HP:0000132) | 2.05189128 |
| 99 | Hyperglycinuria (HP:0003108) | 2.04423811 |
| 100 | Abnormality of urine glucose concentration (HP:0011016) | 2.02951755 |
| 101 | Glycosuria (HP:0003076) | 2.02951755 |
| 102 | Abnormality of purine metabolism (HP:0004352) | 2.02388428 |
| 103 | Fragile nails (HP:0001808) | 2.02347697 |
| 104 | Palpitations (HP:0001962) | 2.02204653 |
| 105 | Neonatal short-limb short stature (HP:0008921) | 2.01783673 |
| 106 | Polycythemia (HP:0001901) | 2.01638427 |
| 107 | Hyperlipoproteinemia (HP:0010980) | 2.00051986 |
| 108 | Nephrolithiasis (HP:0000787) | 1.99109379 |
| 109 | Nausea (HP:0002018) | 1.98920186 |
| 110 | Hyperammonemia (HP:0001987) | 1.97853462 |
| 111 | Lethargy (HP:0001254) | 1.97374817 |
| 112 | Hypoalphalipoproteinemia (HP:0003233) | 1.96646670 |
| 113 | Atrophic scars (HP:0001075) | 1.95016561 |
| 114 | Hyperbilirubinemia (HP:0002904) | 1.94574834 |
| 115 | Abnormal biliary tract morphology (HP:0012440) | 1.93937018 |
| 116 | Alkalosis (HP:0001948) | 1.93745289 |
| 117 | Mitral stenosis (HP:0001718) | 1.93704854 |
| 118 | Progressive macrocephaly (HP:0004481) | 1.92466577 |
| 119 | Biliary tract neoplasm (HP:0100574) | 1.91320560 |
| 120 | Poikilocytosis (HP:0004447) | 1.90553403 |
| 121 | Aneurysm (HP:0002617) | 1.90057480 |
| 122 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.89778344 |
| 123 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.89620821 |
| 124 | Late onset (HP:0003584) | 1.89129029 |
| 125 | Wormian bones (HP:0002645) | 1.88658565 |
| 126 | Onycholysis (HP:0001806) | 1.88398743 |
| 127 | Exocrine pancreatic insufficiency (HP:0001738) | 1.88263680 |
| 128 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.86424498 |
| 129 | Gastrointestinal dysmotility (HP:0002579) | 1.85455655 |
| 130 | Irregular epiphyses (HP:0010582) | 1.85252114 |
| 131 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.85081058 |
| 132 | Chondrocalcinosis (HP:0000934) | 1.84189849 |
| 133 | Abnormal finger flexion creases (HP:0006143) | 1.83876510 |
| 134 | Epidermoid cyst (HP:0200040) | 1.83507094 |
| 135 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82603422 |
| 136 | Abnormal glucose tolerance (HP:0001952) | 1.80694188 |
| 137 | Hypophosphatemia (HP:0002148) | 1.80338271 |
| 138 | Abnormality of Sharpey fibers (HP:0100685) | 1.80124768 |
| 139 | Progressive hearing impairment (HP:0001730) | 1.80120971 |
| 140 | Cholecystitis (HP:0001082) | 1.80111445 |
| 141 | Abnormal gallbladder physiology (HP:0012438) | 1.80111445 |
| 142 | Popliteal pterygium (HP:0009756) | 1.78802942 |
| 143 | Abnormality of the intrinsic pathway (HP:0010989) | 1.78499482 |
| 144 | Vertebral hypoplasia (HP:0008417) | 1.77107464 |
| 145 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.77107464 |
| 146 | Congenital sensorineural hearing impairment (HP:0008527) | 1.76481611 |
| 147 | Focal segmental glomerulosclerosis (HP:0000097) | 1.76332524 |
| 148 | Follicular hyperkeratosis (HP:0007502) | 1.75567787 |
| 149 | Rickets (HP:0002748) | 1.75037906 |
| 150 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.74965958 |
| 151 | Growth hormone excess (HP:0000845) | 1.74939568 |
| 152 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74325411 |
| 153 | Dicarboxylic aciduria (HP:0003215) | 1.74325411 |
| 154 | Megaloblastic anemia (HP:0001889) | 1.74147820 |
| 155 | Abnormality of the acetabulum (HP:0003170) | 1.74015857 |
| 156 | Hyperaldosteronism (HP:0000859) | 1.73944149 |
| 157 | Abnormality of the common coagulation pathway (HP:0010990) | 1.73300347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CA | 6.37888280 |
| 2 | FRK | 6.09017648 |
| 3 | MST1R | 3.83296691 |
| 4 | ACVR1B | 3.74117248 |
| 5 | LMTK2 | 3.64148051 |
| 6 | MAP3K2 | 3.17381754 |
| 7 | MAP2K2 | 3.09090692 |
| 8 | RIPK1 | 3.08091213 |
| 9 | TESK1 | 2.78136622 |
| 10 | GRK5 | 2.51714530 |
| 11 | LIMK1 | 2.30004975 |
| 12 | KSR2 | 2.14963898 |
| 13 | MST4 | 2.07081869 |
| 14 | PRKG2 | 2.06423555 |
| 15 | MYLK | 2.02789022 |
| 16 | LATS1 | 1.85558983 |
| 17 | MET | 1.78317468 |
| 18 | EPHB2 | 1.77367636 |
| 19 | TGFBR2 | 1.69377558 |
| 20 | MAP2K1 | 1.50851761 |
| 21 | BCKDK | 1.50193175 |
| 22 | EPHA2 | 1.46359039 |
| 23 | MAP3K12 | 1.43431324 |
| 24 | TIE1 | 1.36153712 |
| 25 | PDK2 | 1.28272495 |
| 26 | LATS2 | 1.27700585 |
| 27 | RIPK4 | 1.24655434 |
| 28 | DDR2 | 1.21093956 |
| 29 | PAK4 | 1.17284429 |
| 30 | CAMK2D | 1.16442585 |
| 31 | PIM2 | 1.15386096 |
| 32 | FER | 1.15206140 |
| 33 | NME2 | 1.14803645 |
| 34 | NME1 | 1.13131037 |
| 35 | TRPM7 | 1.11328899 |
| 36 | RPS6KB2 | 1.05790304 |
| 37 | PTK2 | 1.05143678 |
| 38 | NTRK1 | 1.01425983 |
| 39 | WNK4 | 0.98630355 |
| 40 | ARAF | 0.98167431 |
| 41 | PRKCI | 0.92835551 |
| 42 | MAP3K3 | 0.91690143 |
| 43 | EPHB1 | 0.85997649 |
| 44 | EPHA3 | 0.85312275 |
| 45 | PDGFRB | 0.81922523 |
| 46 | TAOK1 | 0.81226914 |
| 47 | FGFR2 | 0.79941296 |
| 48 | NLK | 0.78633264 |
| 49 | STK3 | 0.76982600 |
| 50 | MAP3K14 | 0.76854348 |
| 51 | JAK1 | 0.76029944 |
| 52 | MARK3 | 0.72442867 |
| 53 | YES1 | 0.70248996 |
| 54 | TESK2 | 0.69411863 |
| 55 | MAP3K9 | 0.69087890 |
| 56 | OXSR1 | 0.67229740 |
| 57 | MAP3K1 | 0.67141201 |
| 58 | SIK1 | 0.66619823 |
| 59 | GRK1 | 0.66551636 |
| 60 | MAPKAPK5 | 0.65277087 |
| 61 | RET | 0.63054626 |
| 62 | ERBB3 | 0.62971512 |
| 63 | LRRK2 | 0.62774746 |
| 64 | ICK | 0.62723374 |
| 65 | EIF2AK3 | 0.62180868 |
| 66 | EIF2AK1 | 0.61824514 |
| 67 | NEK1 | 0.60987309 |
| 68 | IRAK3 | 0.60252219 |
| 69 | STK38L | 0.59066087 |
| 70 | PKN2 | 0.58087990 |
| 71 | STK10 | 0.57726924 |
| 72 | FGFR4 | 0.57699206 |
| 73 | TYK2 | 0.57090800 |
| 74 | MAP3K7 | 0.55830689 |
| 75 | DAPK2 | 0.55346606 |
| 76 | NEK9 | 0.54657253 |
| 77 | MAP3K11 | 0.54282013 |
| 78 | BRSK2 | 0.53908644 |
| 79 | ROCK1 | 0.53474639 |
| 80 | KDR | 0.51373935 |
| 81 | CAMK2G | 0.49787419 |
| 82 | PAK3 | 0.49750371 |
| 83 | BMPR2 | 0.49155025 |
| 84 | SGK494 | 0.48344339 |
| 85 | SGK223 | 0.48344339 |
| 86 | DAPK3 | 0.47931387 |
| 87 | BMPR1B | 0.47696818 |
| 88 | PBK | 0.47404911 |
| 89 | GRK7 | 0.47307966 |
| 90 | BMX | 0.47264314 |
| 91 | PIK3CG | 0.47184771 |
| 92 | ERN1 | 0.46706445 |
| 93 | CDC42BPA | 0.46484958 |
| 94 | MUSK | 0.45237951 |
| 95 | PDGFRA | 0.44036561 |
| 96 | FGFR1 | 0.43907482 |
| 97 | SGK2 | 0.42753880 |
| 98 | MATK | 0.42017350 |
| 99 | MAPKAPK3 | 0.41799942 |
| 100 | ABL2 | 0.41605881 |
| 101 | AKT3 | 0.41430385 |
| 102 | DMPK | 0.41085222 |
| 103 | STK39 | 0.40050509 |
| 104 | CDK6 | 0.39676372 |
| 105 | INSRR | 0.39573945 |
| 106 | MELK | 0.39289542 |
| 107 | MAP3K8 | 0.38219435 |
| 108 | PAK2 | 0.38156851 |
| 109 | SGK3 | 0.37747358 |
| 110 | BCR | 0.37737757 |
| 111 | STK24 | 0.36714512 |
| 112 | MAP3K10 | 0.36112629 |
| 113 | SCYL2 | 0.35720810 |
| 114 | ZAK | 0.35004937 |
| 115 | CAMK2B | 0.34835803 |
| 116 | PTK6 | 0.33656440 |
| 117 | DYRK1B | 0.33509949 |
| 118 | PRPF4B | 0.33154149 |
| 119 | WNK1 | 0.32408915 |
| 120 | STK38 | 0.32267749 |
| 121 | ADRBK1 | 0.32179448 |
| 122 | PRKAA2 | 0.32179090 |
| 123 | MAPKAPK2 | 0.31787249 |
| 124 | PRKCA | 0.30821172 |
| 125 | IGF1R | 0.30579077 |
| 126 | EPHA4 | 0.29597579 |
| 127 | PDK1 | 0.29126915 |
| 128 | GRK6 | 0.29120719 |
| 129 | SRC | 0.28910941 |
| 130 | BRAF | 0.28220215 |
| 131 | MAPK11 | 0.27924223 |
| 132 | PRKACG | 0.27128651 |
| 133 | FLT3 | 0.26881811 |
| 134 | ERBB4 | 0.26802102 |
| 135 | AURKB | 0.24352800 |
| 136 | TTK | 0.22881694 |
| 137 | CDK14 | 0.22224116 |
| 138 | PDPK1 | 0.21857543 |
| 139 | ERBB2 | 0.21399924 |
| 140 | WNK3 | 0.20829009 |
| 141 | FGFR3 | 0.20616442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.33231553 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.47330282 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.95454569 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.94828326 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.61566886 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.57169737 |
| 7 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.52159402 |
| 8 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.44567531 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.41426136 |
| 10 | Bile secretion_Homo sapiens_hsa04976 | 2.32922371 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 2.21059566 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20123619 |
| 13 | Mineral absorption_Homo sapiens_hsa04978 | 2.17872540 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.14404569 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.03875325 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89491419 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.84607992 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81798791 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.77243052 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.69826953 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68044398 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.67347788 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.57516106 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46970007 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.45583630 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.43268994 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.38801369 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34993075 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26640120 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.26584280 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.26577191 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.25651003 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23210159 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.23123793 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20581012 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20380615 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.19692084 |
| 38 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.19084503 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16781140 |
| 40 | Alzheimers disease_Homo sapiens_hsa05010 | 1.16185106 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16180998 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14907485 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.13091339 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10568289 |
| 45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08606765 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.05683901 |
| 47 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.02296459 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01651017 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97614982 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97105623 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94601159 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94576075 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92316190 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91731239 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90180817 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86383194 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86016418 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84645865 |
| 59 | Tight junction_Homo sapiens_hsa04530 | 0.84227978 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81598631 |
| 61 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79154190 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.79022722 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78105482 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74697784 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74672999 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73943692 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72828363 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72803899 |
| 69 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.70432853 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63986906 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63626349 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60279717 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60028971 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58192626 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57201705 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55926315 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.52853219 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52739627 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.52125578 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51919499 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47585204 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.46033402 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45522086 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45225143 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44995867 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44214471 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43815518 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40595959 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.40316565 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.39865831 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39813026 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.38692725 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38106062 |
| 94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37837935 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.35489019 |
| 96 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31957631 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31579078 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.30419411 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29605352 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29412159 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27536027 |
| 102 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.26115533 |
| 103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.25950836 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25877271 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.25104989 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24336886 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23304968 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.23010064 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22954078 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.21257037 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.21060305 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20393621 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.19190628 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.18650884 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.17168411 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.17090498 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16194295 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15485699 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13840804 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11326084 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10872596 |
| 122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.09986835 |

